Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CBMG

Cellular Biomedicine Group (CBMG) Stock Price, News & Analysis

Cellular Biomedicine Group logo

About Cellular Biomedicine Group Stock (NASDAQ:CBMG)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$17.67
$19.75
52-Week Range
N/A
Volume
8,375 shs
Average Volume
129,776 shs
Market Capitalization
$384.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CBMG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellular Biomedicine Group and its competitors with MarketBeat's FREE daily newsletter.

CBMG Stock News Headlines

President Trump’s Project MAFA
President Trump’s Boldest Initiative Yet First came “Make America Great Again” (MAGA)… Then came “Make America Healthy Again” (MAHA)… Now comes President Trump’s boldest initiative yet. After a gathering in D.C. with some of the most powerful people in the world, Jeff Brown is now revealing the full details on “Project MAFA.” It’s a revolutionary plan to return America to an era of sound money, eliminate our looming debt disaster, kick off a Golden Century, and more – by July 25. Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%. Jeff Brown is sharing the details Wednesday, July 16, at 8 p.m. ET – including the name of a stock set to profit.
See More Headlines

CBMG Stock Analysis - Frequently Asked Questions

Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) issued its quarterly earnings data on Monday, November, 9th. The biotechnology company reported ($0.88) EPS for the quarter, missing analysts' consensus estimates of ($0.63) by $0.25. The biotechnology company earned $0.03 million during the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cellular Biomedicine Group investors own include CRISPR Therapeutics (CRSP), Anavex Life Sciences (AVXL), Aduro Biotech (ADRO), Allena Pharmaceuticals (ALNA), Amarin (AMRN), Bristol Myers Squibb (BMY) and Intellia Therapeutics (NTLA).

Company Calendar

Last Earnings
11/09/2020
Today
7/14/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:CBMG
CIK
1378624
Fax
N/A
Employees
217
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$49.98 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-144.80%
Return on Assets
-61.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.47
Quick Ratio
0.47

Sales & Book Value

Annual Sales
$340 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.89 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
19,478,000
Free Float
N/A
Market Cap
$384.69 million
Optionable
Optionable
Beta
1.35
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:CBMG) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners